Author: Iacoviello, Massimo; Palazzuoli, Alberto; Gronda, Edoardo
Title: Recent advances in pharmacological treatment of heart failure. Cord-id: 83mkcp99 Document date: 2021_5_27
ID: 83mkcp99
Snippet: Over the last years, several trials offered new evidence on heart failure (HF) treatment. For HF with reduced left ventricular ejection fraction, type 2 sodium-glucose cotransporter inhibitors, aside from sacubitril-valsartan, demonstrated extraordinary efficacy in ameliorating patients' prognosis. Some new molecules (e.g. vericiguat, omecamtiv mecarbil and ferric carboxymaltose) correct iron deficiency and have shown to be capable of furthering reducing the burden of HF hospitalisation.
Document: Over the last years, several trials offered new evidence on heart failure (HF) treatment. For HF with reduced left ventricular ejection fraction, type 2 sodium-glucose cotransporter inhibitors, aside from sacubitril-valsartan, demonstrated extraordinary efficacy in ameliorating patients' prognosis. Some new molecules (e.g. vericiguat, omecamtiv mecarbil and ferric carboxymaltose) correct iron deficiency and have shown to be capable of furthering reducing the burden of HF hospitalisation.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date